ClinicalTrials.Veeva

Menu

Smoking Cessation Program Among Adolescents in Vocational Training Centers (TABADO)

I

Institut National de la Santé Et de la Recherche Médicale, France

Status

Completed

Conditions

Tobacco Use

Treatments

Behavioral: TABADO program

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Background: Most of the efforts to fight against young people's tobacco addiction have focused on smoking prevention and little on smoking cessation. A smoking cessation program, associating pharmacologic and cognitive-behavioural strategy, on a particularly vulnerable population (vocational trainees), was developed by a team of tobacco addiction specialist physicians. We developed a study to evaluate the efficacy of the program. Its main objective is to compare the efficacy of a smoking cessation program offered to all smokers in a population aged 15 to 20 years in Vocational Training Centers (VTC) with that in a control population. The objective of this paper is to present the TABADO study protocol and the results of the pilot study.

Methods: The study is quasi-experimental, prospective, evaluative and comparative and takes place during the 2 years of vocational training. The final population will be composed of 2000 trainees entering a VTC (in Lorraine, France): The intervention group (1000 trainees) benefited from the TABADO program while no specific intervention took place in the "control" group (1000 trainees) other than the treatment and education services usually available. Our primary outcome will be the tobacco abstinence rate at 12 months.

The pilot study is a descriptive monocentric cross-sectional study conducted among the whole group of students, completed by a longitudinal prospective study of smoker volunteers.

Enrollment

2,000 patients

Sex

All

Ages

15 to 20 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All students, males and females, registered in the VTC for at least a 2-year training period
  • Aged from 15 to 20 years

Exclusion criteria

  • Subjects with current serious psychiatric disorders or who may be susceptible to decompensation upon quitting smoking (major depression)
  • Smokers who are involved in an ongoing attempt to quit, with medical monitoring.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,000 participants in 2 patient groups

"Intervention" group
Experimental group
Description:
The "intervention" group benefits from the TABADO program
Treatment:
Behavioral: TABADO program
"Control" group
No Intervention group
Description:
The "control" group not benefit from any specific intervention other than the treatment and education usually available

Trial contacts and locations

1

Loading...

Central trial contact

Laetitia MINARY, MSc; François ALLA, MD/ PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems